CSS LLC’s Avanos Medical AVNS Stock Holding History

CSS LLC’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,000	Closed	-$244K	–	734
2022 Q4	$244K	Sell	9,000 -3,000	-25%	-$73.4K	0.01%	580
2022 Q3	$261K	Buy	+12,000	New	+$314K	0.01%	699

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CSS LLC's AVNS Position: Q1 2023 in Review

CSS LLC sold out of Avanos Medical (AVNS) in Q1 2023, closing a stake of 9,000 shares — an estimated $244K sold.

CSS LLC first reported a position in AVNS in Q3 2022 and held it in 2 quarters. The position peaked at $261K in Q3 2022. 287 funds tracked by Wall St. Rank hold AVNS as of Q1 2023.

CSS LLC reported no remaining Avanos Medical position as of Q1 2023 after selling out during the quarter.
CSS LLC sold 9,000 Avanos Medical shares in Q1 2023, an estimated $244K.
CSS LLC first reported a position in Avanos Medical in Q3 2022 and held it in 2 quarters.
CSS LLC's Avanos Medical position peaked at $261K in Q3 2022.
287 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2023.

Based on CSS LLC's 13F filing for Q1 2023, filed 15 May 2023.